HC Wainwright & Co. Reiterates Buy on Evotec, Maintains $12 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Douglas Tsao has reiterated a 'Buy' rating on Evotec (NASDAQ:EVO) and maintained a $12 price target.
July 12, 2023 | 10:10 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Evotec's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $12.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. The maintained price target of $12 also indicates the firm's confidence in the stock's potential. This could lead to increased investor interest and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100